Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Dr. Zachery Oestreicher is a co-author. Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, Showed ...

QUESTION: Hi Dr Zac, my mum says you are the king of dispelling TikTok influencer trends. I’m 17 years old and I get a lot of my advice from TikTok. I want to stay young and pretty forever haha.

Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the quarter ended September 30, 2024, and ...

Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that, following feedback from the U.S. Food and Drug ...

"There remains a tremendous unmet need in myelofibrosis, as less than half ... eventually stop responding to these treatments," said Dr. Raajit Rampal, Director of the Center for Hematologic ...

Here’s how it works. When it comes to starting points in the Classic Era, you should be ok beginning with any of the first seven Doctors, although going from the Third Doctor onwards keeps you ...

Can anyone make it stop? By Nancy Scola. Photograph by Magdalena Papaioannou. More than 2,100 of the region’s best physicians, as chosen by their peers. Did your doctor make the list? Plus, the area’s ...

Each spring, we ask nearly 13,000 doctors in DC, Maryland, & Virginia to tell us which colleague they would recommend in a variety of specialties. To ensure the data’s accuracy, each physician was ...